Application 018297
- Type
- NDA
- Sponsor
- ABBOTT
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LOPURIN | ALLOPURINOL | TABLET;ORAL | 100MG | No | No |
| 002 | LOPURIN | ALLOPURINOL | TABLET;ORAL | 300MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N018297-001 | LOPURIN | ALLOPURINOL | 100MG | TABLET / ORAL | Approved before 1982 | ||
| N018297-002 | LOPURIN | ALLOPURINOL | 300MG | TABLET / ORAL | Approved before 1982 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N018297-001 | LOPURIN | 100MG | TABLET / ORAL | Approved before 1982 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N018297-002 | LOPURIN | 300MG | TABLET / ORAL | Approved before 1982 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | N018297-001 | LOPURIN | 100MG | TABLET / ORAL | Approved before 1982 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N018297-002 | LOPURIN | 300MG | TABLET / ORAL | Approved before 1982 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N018297-001 | LOPURIN | 100MG | TABLET / ORAL | Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N018297-002 | LOPURIN | 300MG | TABLET / ORAL | Approved before 1982 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018297-001 | LOPURIN | 100MG | TABLET / ORAL | Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018297-002 | LOPURIN | 300MG | TABLET / ORAL | Approved before 1982 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N018297-001 | LOPURIN | 100MG | TABLET / ORAL | Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N018297-002 | LOPURIN | 300MG | TABLET / ORAL | Approved before 1982 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N018297-001 | LOPURIN | 100MG | TABLET / ORAL | Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N018297-002 | LOPURIN | 300MG | TABLET / ORAL | Approved before 1982 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N018297-001 | LOPURIN | 100MG | TABLET / ORAL | Approved before 1982 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N018297-002 | LOPURIN | 300MG | TABLET / ORAL | Approved before 1982 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N018297-001 | LOPURIN | 100MG | TABLET / ORAL | Approved before 1982 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N018297-002 | LOPURIN | 300MG | TABLET / ORAL | Approved before 1982 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N018297-001 | LOPURIN | 100MG | TABLET / ORAL | Approved before 1982 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N018297-002 | LOPURIN | 300MG | TABLET / ORAL | Approved before 1982 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N018297-001 | LOPURIN | 100MG | TABLET / ORAL | Approved before 1982 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N018297-002 | LOPURIN | 300MG | TABLET / ORAL | Approved before 1982 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N018297-001 | LOPURIN | 100MG | TABLET / ORAL | Approved before 1982 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N018297-002 | LOPURIN | 300MG | TABLET / ORAL | Approved before 1982 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N018297-001 | LOPURIN | 100MG | TABLET / ORAL | Approved before 1982 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N018297-002 | LOPURIN | 300MG | TABLET / ORAL | Approved before 1982 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N018297-001 | LOPURIN | 100MG | TABLET / ORAL | Approved before 1982 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N018297-002 | LOPURIN | 300MG | TABLET / ORAL | Approved before 1982 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N018297-001 | LOPURIN | 100MG | TABLET / ORAL | Approved before 1982 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N018297-002 | LOPURIN | 300MG | TABLET / ORAL | Approved before 1982 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N018297-001 | LOPURIN | 100MG | TABLET / ORAL | Approved before 1982 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N018297-002 | LOPURIN | 300MG | TABLET / ORAL | Approved before 1982 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | N018297-001 | LOPURIN | 100MG | TABLET / ORAL | Approved before 1982 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | N018297-002 | LOPURIN | 300MG | TABLET / ORAL | Approved before 1982 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N018297-001 | LOPURIN | 100MG | TABLET / ORAL | Approved before 1982 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N018297-002 | LOPURIN | 300MG | TABLET / ORAL | Approved before 1982 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N018297-001 | LOPURIN | 100MG | TABLET / ORAL | Approved before 1982 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N018297-002 | LOPURIN | 300MG | TABLET / ORAL | Approved before 1982 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N018297-001 | LOPURIN | 100MG | TABLET / ORAL | Approved before 1982 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N018297-002 | LOPURIN | 300MG | TABLET / ORAL | Approved before 1982 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N018297-001 | LOPURIN | 100MG | TABLET / ORAL | Approved before 1982 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N018297-002 | LOPURIN | 300MG | TABLET / ORAL | Approved before 1982 | 74a2ff9319b5… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Allopurinol | ALLOPURINOL | St. Mary's Medical Park Pharmacy | 0f8b97d0-4d0b-9f4a-e063-6294a90a033f | 2026-06-04 | Warnings, Adverse reactions | ALLOPURINOL |
| Allopurinol | ALLOPURINOL | St. Mary's Medical Park Pharmacy | 00b27899-e68f-e9d9-e063-6394a90a88cb | 2026-06-03 | Warnings, Adverse reactions | ALLOPURINOL |
| Allopurinol | ALLOPURINOL | Major Pharmaceuticals | b630c1cb-d4b7-4f80-b252-5947c1887def | 2026-06-01 | Warnings, Adverse reactions | ALLOPURINOL |
| Allopurinol | ALLOPURINOL | Rising Pharma Holdings, Inc. | 30ad5ba2-1cef-4933-b104-0597f6a2aaa2 | 2026-05-21 | Warnings, Adverse reactions | ALLOPURINOL |
| Allopurinol | ALLOPURINOL | Bryant Ranch Prepack | 3bcd1381-34d9-4fa5-bfc5-2566cb7a7638 | 2026-05-21 | Warnings, Adverse reactions | ALLOPURINOL |
| Allopurinol | ALLOPURINOL | Bryant Ranch Prepack | 76ed9122-b845-423b-a6d5-a47b31743317 | 2026-05-19 | Warnings, Adverse reactions | ALLOPURINOL |
| Allopurinol | ALLOPURINOL | Bryant Ranch Prepack | 1f626471-153c-4740-8019-9089ea741684 | 2026-05-15 | Warnings, Adverse reactions | ALLOPURINOL |
| Allopurinol | ALLOPURINOL | Bryant Ranch Prepack | fc37bc7e-b6bc-4aa9-a6f3-6e11285c4f05 | 2026-05-13 | Warnings, Adverse reactions | ALLOPURINOL |
| ALLOPURINOL | ALLOPURINOL | Northwind Health Company, LLC | 4deeebe3-fccc-2082-e063-6294a90a0c78 | 2026-05-11 | Warnings, Adverse reactions | ALLOPURINOL |
| Allopurinol | ALLOPURINOL | Cardinal Health 107, LLC | 1ce96b87-323d-40b6-a40b-32821e00d94c | 2026-04-20 | Warnings, Adverse reactions | ALLOPURINOL |
| Allopurinol | ALLOPURINOL | Aurobindo Pharma Limited | 311ca755-c022-4251-97eb-dd9be86a993f | 2026-04-17 | Warnings, Adverse reactions | ALLOPURINOL |
| Allopurinol | ALLOPURINOL | Bryant Ranch Prepack | 30529a62-f95a-40e0-b4c5-2cfc09232068 | 2026-04-15 | Warnings, Adverse reactions | ALLOPURINOL |
| Allopurinol | ALLOPURINOL | Bryant Ranch Prepack | 8ae2d634-df53-40a8-a6bd-6fee7dacd754 | 2026-04-15 | Warnings, Adverse reactions | ALLOPURINOL |
| Allopurinol | ALLOPURINOL | ST. MARY'S MEDICAL PARK PHARMACY | 4f5c4fbc-3d31-5068-e063-6294a90ab315 | 2026-04-13 | Warnings, Adverse reactions | ALLOPURINOL |
| Allopurinol | ALLOPURINOL | Bryant Ranch Prepack | 5dca2d4f-0e93-4d1a-8d9f-b9b72867c242 | 2026-04-13 | Warnings, Adverse reactions | ALLOPURINOL |
| Allopurinol | ALLOPURINOL | Cardinal Health 107, LLC | 2462b4b5-8313-4e4d-93ac-839de4a29520 | 2026-04-08 | Warnings, Adverse reactions | ALLOPURINOL |
| Allopurinol | ALLOPURINOL | Safecor Health, LLC | dbfb3bde-2274-43cc-b726-d4578ebdb5d4 | 2026-04-01 | Warnings, Adverse reactions | ALLOPURINOL |
| Allopurinol | ALLOPURINOL | Direct_Rx | f6c83ee9-c07b-9fc8-e053-6394a90a2160 | 2026-03-05 | Warnings, Adverse reactions | ALLOPURINOL |
| ALLOPURINOL | ALLOPURINOL | Direct_Rx | f3bd5852-8e43-6b5d-e053-2995a90a194f | 2026-03-05 | Warnings, Adverse reactions | ALLOPURINOL |
| Allopurinol | ALLOPURINOL | Chartwell RX, LLC | cdc3f33b-ff2b-4a84-a820-51a497fdf3d9 | 2026-02-20 | Warnings, Adverse reactions | ALLOPURINOL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.